Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1

FAA Sanad, SF Ahmed… - Archives of physiology …, 2022 - Taylor & Francis
Objectives The aim of the current study is to investigate the antidiabetic and hypolipidemic
potentials of Solidago virgaurea extract in alloxan-induced diabetic rats. Materials and …

Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1.

FAA Sanad, SF Ahmed, WH El-Tantawy - 2022 - cabidigitallibrary.org
Objectives: The aim of the current study is to investigate the antidiabetic and hypolipidemic
potentials of Solidago virgaurea extract in alloxan-induced diabetic rats. Materials and …

Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1

FAA Sanad, SF Ahmed… - Archives of physiology …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of the current study is to investigate the antidiabetic and hypolipidemic
potentials of Solidago virgaurea extract in alloxan-induced diabetic rats. Materials and …

[PDF][PDF] Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type

FAA Sanad, SF Ahmed… - … OF PHYSIOLOGY AND …, 2022 - researchgate.net
Objectives: The aim of the current study is to investigate the antidiabetic and hypolipidemic
potentials of Solidago virgaurea extract in alloxan-induced diabetic rats. Materials and …

Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1.

FA Sanad, SF Ahmed, WH El-Tantawy - Archives of Physiology and …, 2020 - europepmc.org
Objectives The aim of the current study is to investigate the antidiabetic and hypolipidemic
potentials of Solidago virgaurea extract in alloxan-induced diabetic rats. Materials and …